INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |
| GREAT POINT PARTNERS LLC | 225,000 | $11,720,250 | 2.14% |
| Avidity Partners Management LP | 801,100 | $41,729,299 | 1.68% |
| Privium Fund Management B.V. | 93,650 | $4,878,229 | 1.45% |
| Nicholas Investment Partners, LP | 335,554 | $17,479,008 | 1.30% |
| SECTORAL ASSET MANAGEMENT INC | 123,680 | $6,442,491 | 1.26% |
| Pier Capital, LLC | 149,129 | $7,768,130 | 1.25% |
| WASATCH ADVISORS LP | 3,803,139 | $198,105,511 | 1.25% |
| GENERAL AMERICAN INVESTORS CO INC | 260,439 | $13,566,268 | 1.22% |
| 1492 Capital Management LLC | 34,932 | $1,819,608 | 1.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 311,438 | $16,222,805 | 0.98% |
External links
This page lists INTRA CELLULAR THERAPIES INC's shareholders in Q3 2023. To view INTRA CELLULAR THERAPIES INC's shareholder history, click here.